{
    "medicine_id": "ba20929759f80f5bed2cd2b79b6d5c9591e4a01b",
    "platform_id": "DB12834",
    "metadata": {
        "name": "Solosec 2 g 4 8g Granule",
        "composition": "2 g 4 8g Secnidazole",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated for the treatment of bacterial vaginosis in adult women",
            "contraindications": {
                "disease": "Oral LD50 in mouse rabbit and rat is 300 mg kg 3200 mg kg and 980 mg kg in a respective order MSDS Secnidazole was positive in the Bacterial Reverse Mutation Assay but was negative for the rat micronucleus test and mouse lymphoma test No parental toxicity or signs of reproductive toxicity were observed in female rat fertility studies at doses of up to the maximum tolerated dose of 300 mg kg day FDA Label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Secnidazole is a nitroimidazole antimicrobial drug that displays selectivity against many anaerobic Gram positive and Gram negative bacteria and protozoa A27210 In vitro studies demonstrates the effectiveness of the drug against Bacteroides fragilis Trichomonas vaginalis Entamoeba histolytica and Giardia lamblia A27210 There is no significant bacterial or protozoal resistance reported from secnidazole treatment A27210",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}